NCAM1 and fecal incontinence: In contrast, skeletal muscle-derived cells are highly proliferative [50], and CD56+ cells have been shown to be safe and effective in clinical trials to treat external anal sphincter-associated (skeletal muscle) fecal incontinence [21, 22, 24].